Brinton Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 1.09 Cr
as on 15-12-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 47.75 Cr
as on 15-12-2024
- Satisfied Charges ₹ 35.00 Cr
as on 15-12-2024
- Revenue 13.33%
(FY 2022)
- Profit 160.49%
(FY 2022)
- Ebitda 111.29%
(FY 2022)
- Net Worth 54.08%
(FY 2022)
- Total Assets 42.39%
(FY 2022)
About Brinton Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.09 Cr.
The company currently has active open charges totaling ₹47.75 Cr. The company has closed loans amounting to ₹35.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Brinton Pharmaceuticals Limited India are Chandra Singh as CFO and Neha Pandya as Company Secretary. Rahul Darda, Shivani Bhasin, Vijey Victor, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24232PN2013PLC148971
- Company No.
148971
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Brinton Pharmaceuticals Limited offer?
Brinton Pharmaceuticals Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiviral Drugs, Face Mask & Medical PPE Kits, Personal Protective Equipment, Skin Care, Bath Essentials, Hair Care, Hair Growth for Men, Facewash, Sunscreen Products.
Who are the key members and board of directors at Brinton Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Darda  | Managing Director | 27-Sep-2013 | Current |
| Chandra Singh | CFO | 25-Oct-2019 | Current |
| Neha Pandya | Company Secretary | 10-Apr-2024 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijey Victor | Director | 30-Sep-2017 | Current |
| Shivani Bhasin | Nominee Director | 13-Jun-2019 | Current |
| Chaitali Darda | Director | 27-Sep-2013 | Current |
| Visalakshi Chandramouli | Nominee Director | 30-Mar-2017 | Current |
| Sudeep Chhallani | Director | 28-Mar-2024 | Current |
| Ronak Shah | Director | 28-Mar-2024 | Current |
Financial Performance and Corporate Structure Insights of Brinton Pharmaceuticals.
Brinton Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.33% increase. The company also saw a substantial improvement in profitability, with a 160.49% increase in profit. The company's net worth Soared by an impressive increase of 54.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brinton Pharmaceuticals?
In 2021, Brinton Pharmaceuticals had a promoter holding of 87.84% and a public holding of 12.15%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Linux Laboratories Private LimitedActive 13 years 2 monthsVisalakshi Chandramouli is a mutual person
Anderson Diagnostic Services Private LimitedActive 13 years 2 monthsVisalakshi Chandramouli is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Sep 2024 | ₹4.00 Cr | Open |
Others Creation Date: 27 Jun 2023 | ₹7.50 Cr | Open |
Others Creation Date: 09 Jun 2023 | ₹3.00 Cr | Open |
How Many Employees Work at Brinton Pharmaceuticals?
Brinton Pharmaceuticals has a workforce of 508 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brinton Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brinton Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
